RCM
RA Capital Management Portfolio holdings
AUM
$5.94B
1-Year Return
18.15%
This Quarter Return
+43.99%
1 Year Return
+18.15%
3 Year Return
+417.5%
5 Year Return
+458.13%
10 Year Return
+21,247.51%
AUM
$2.32B
AUM Growth
+$601M
(+35%)
Cap. Flow
+$128M
Cap. Flow
% of AUM
5.52%
Top 10 Holdings %
Top 10 Hldgs %
72.02%
Holding
31
New
6
Increased
4
Reduced
7
Closed
2
Top Buys
| 1 |
SAGE
Sage Therapeutics
SAGE
|
$61.1M |
| 2 |
Axsome Therapeutics
AXSM
|
$46.9M |
| 3 |
Precision BioSciences
DTIL
|
$33.1M |
| 4 |
InflaRx
IFRX
|
$27.4M |
| 5 |
Alector
ALEC
|
$18.7M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$43.1M |
| 2 |
BioCryst Pharmaceuticals
BCRX
|
$16.3M |
| 3 |
Arvinas
ARVN
|
$14.8M |
| 4 |
Ascendis Pharma
ASND
|
$12.7M |
| 5 |
MYOV
Myovant Sciences Ltd.
MYOV
|
$3.99M |
Sector Composition
| 1 | Healthcare | 98.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Alector
ALEC
$305M
| $18.7M | 0.81% |
+1,000,000
| New | +$18.7M |
|
|
SWAV
27
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $16.6M | 0.72% |
+495,608
| New | +$16.6M |
|
28
scPharmaceuticals
SCPH
$299M
| $8.57M | 0.37% |
2,857,143
| – | – |
|
|
GTHX
29
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $6.03M | 0.26% |
+363,051
| New | +$6.03M |
|
30
Protara Therapeutics
TARA
$122M
| – | – |
-33,437
| Closed | -$3.04M |
|
|
IMMU
31
DELISTED
Immunomedics Inc
IMMU
| – | – |
-3,021,466
| Closed | -$43.1M |
|